NCT02093390View on ClinicalTrials.gov

A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Prostate CancerEndometriosis
Interventions
DRUG

TAK-385

TAK-385 tablets

DRUG

Fluconazole

Fluconazole tablets

DRUG

Atorvastatin

Atorvastatin tablets

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY

NCT02093390 - A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects | Biotech Hunter | Biotech Hunter